Compare PTGX & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | SFL |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 1.0B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | SFL |
|---|---|---|
| Price | $94.91 | $7.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $88.33 | $11.00 |
| AVG Volume (30 Days) | 953.6K | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-11-2025 |
| Dividend Yield | N/A | ★ 13.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $774,521,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $296.47 | N/A |
| P/E Ratio | $132.39 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $6.73 |
| 52 Week High | $95.39 | $11.14 |
| Indicator | PTGX | SFL |
|---|---|---|
| Relative Strength Index (RSI) | 70.99 | 40.46 |
| Support Level | $88.30 | $8.24 |
| Resistance Level | $92.80 | $8.42 |
| Average True Range (ATR) | 2.82 | 0.16 |
| MACD | 0.19 | -0.06 |
| Stochastic Oscillator | 94.19 | 11.27 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.